Table S1.
Annual medication costs and patient share of medication costs among children with eczema, asthma, or hay fever compared with children without
| Atopic disease | Medication costs (€) | Patient share of medication costs (€) |
|---|---|---|
|
| ||
| Mean difference (95% CI) | Mean difference (95% CI) | |
| Eczema | ||
| Known disease ever | 19.90 (8.88–30.91) | 6.93 (4.65–9.20) |
| Current symptoms | 33.27 (13.16–53.37) | 10.80 (6.33–15.27) |
| Asthma | ||
| Known disease ever | 92.21 (55.27–129.16) | 20.35 (15.47–25.24) |
| Current symptoms | 55.46 (35.41–75.50) | 17.90 (12.99–22.82) |
| Hay fever | ||
| Known disease ever | 26.56 (2.05–51.06) | 8.27 (4.72–11.82) |
| Current symptomsa | 46.43 (15.69–77.18) | 9.15 (4.93–13.38) |
| Known atopic disease ever | ||
| One vs none | 21.91 (6.94–36.88) | 5.71 (3.52–7.89) |
| Two or more vs none | 63.23 (39.02–87.44) | 20.54 (14.79–26.29) |
| Current symptoms of atopic disease | ||
| One vs none | 25.99 (9.96–42.01) | 6.61 (4.73–8.50) |
| Two or more vs noneb | 95.83 (55.31–136.35) | 28.57 (18.64–38.49) |
Notes: All analyses were adjusted for sex, age, and primary carer’s educational level. Reference categories: known disease ever vs children without the atopic condition ever; current symptoms vs no current symptoms of the atopic condition.
a
Not measured for children aged 3 years.
b
For children aged 3 years, symptoms of up to two diseases could be reported.
Abbreviation: CI, confidence interval.